|
|
Effect identification of GALNT12 on the growth of acute myeloid leukemia cells |
ZHANG Qiang |
Research Center of Medicine and Pharmacy,Binzhou Medical University,Yantai 264003,P.R.China |
|
|
Abstract Objective To explore the effect of GALNT12 expression on the growth of acute myeloid leukemia cells.Methods The relevant data in the acute myeloid leukemia (AML) patients' database were analyzed to clearly explain the relationship between the expression level of GALNT12 mRNA and AML patients' survival.GALNT12 shRNA lentiviral vector was constructed and lentivirus containing GALNT12shRNA was packaged as a tool to construct GALNT12 silenced leukemia THP-1 cell line. The THP-1 cell line infected by the Scramble lentivirus was used as a control group to observe the difference in the growth of THP-1 cells between the silenced GALNT12 and the control group. GFP-positive cells were collected by flow cytometry and used to observe the effect of GALNT12 on the growth of AML cells.Results The expression of GALNT12 was negatively correlated with the survival cycle of AML patients and GALNT12 was highly expressed in acute myeloid leukemia THP-1 cell line. This study successfully constructed GALNT12 silenced leukemia THP-1 cell line.When GALNT12 shRNA1 interferenced THP-1 cells compared with shScramble,the growth rate was significantly slower.Conclusion The expression of GALNT12 can promote the growth of acute myeloid leukemia cells and promote the development of acute myeloid leukemia. It also adds new content to the effective molecular target for the treatment of acute myeloid leukemia.
|
Received: 10 March 2017
|
|
|
|
|
[1] Dombret H,Gardin C.An update of current treatments for adult acute myeloid leukemia[J].Blood,2016,127(1):53-61. [2] Yu C L,Zheng D,Qiao Z H,et al.The long-term outcome of reduced-intensity allogeneic stem cell transplantation from a matched related or unrelated donor,or haploidentical family donor in patients with leukemia:a retrospective analysis of data from the China RIC Cooperative Group[J].Ann Hematol,2017,96(2):279-288. [3] Fathi A,Levis M.FLT3 inhibitors:a story of the old and the new[J].Curr Opin Hematol,2011,18(2):71-76. [4] Vainchenker W,Constantinescu S N.JAK/STAT signaling in hematological malignancies[J].Oncogene,2013,32 (21):2601-2613. [5] Krause D S,Fulzele K,Catic A,et al.Differential regulation of myeloid leukemias by the bone marrow microenvironment[J].Nat Med,2013,19(11):1513-1517. [6] Broxmeyer H E.Chemokines in hematopoiesis[J].Curr Opin Hematol,2008,15(1):49-58. [7] Weng A P,Ferrando A A,Lee W,et al.Activating mutations of NOTCH1 in human T cell acute lymphoblastic leukemia[J].Science,2004,306(5694):269-271. [8] Zhao C,Blum J,Chen A,et al.Loss of beta-catenin impairs the renewal of normal and CML stem cells in vivo[J].Cancer Cell,2007,12(6):528-541. [9] Wang Y,Krivtsov A V,Sinha A U,et al.The Wnt/beta-catenin pathway is required for the development of leukemia stem cells in AML[J].Science,2010,327(5973):1650-1653. [10] Zhao C,Chen A,Jamieson C H,et al.Hedgehog signalling is essential for maintenance of cancer stem cells in myeloid leukaemia[J].Nature,2009,458(7239):776-779. [11] Heidel F H,Mar B G,Armstrong S A.Self-renewal related signaling in myeloid leukemia stem cells[J].Int J Hematol,2011,94(2):109-117. [12] Sands W A,Copland M, Wheadon H.Targeting self-renewal pathways in myeloid malignancies[J].Cell Commun Signal,2013,11(1):33. [13] Bialkowska A,Crisp M,Bannister T,et al.Identi cation of small-molecule inhibitors of the colorectal canceroncogene Kruppel-like factor 5 expression by ultrahigh-throughput screening[J].Mol Cancer Ther,2011,10(11):2043-2051. [14] Cui J,Holmes E C.Endogenous lentiviruses in the ferret genome[J].J Virol,2012,86(6):3383-3385. [15] Keckesova Z,Ylinen L M,Towers G J,et al.Identification of a RELIK orthologue in the European hare (Lepus europaeus) reveals a minimum age of 12 million years for the lagomorph lentiviruses[J].Virology,2009,384(1):7-11. |
[1] |
. [J]. 滨州医学院学报, 2018, 41(2): 145-148. |
[2] |
. [J]. 滨州医学院学报, 2018, 41(2): 159-161. |
|
|
|
|